Showing results (251-260 of 339) with videos related to
Sort By:
Pageof 34
Scientific Reports|February 8, 2025
Severe COVID-19 disease is associated with genetic factors affecting plasma ACE2 receptor and CRP concentrationsVerena Vogi, David Haschka, Lukas Forer, et al.European Journal of Haematology|May 2, 2021
Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centersFelix Goeser, Barbara Sifft, Christoph Stein-Thoeringer, et al.Therapeutic Advances in Medical Oncology|March 11, 2022
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art reviewIsabel Heidegger, Claudia Kesch, Alexander Kretschmer, et al.European Journal of Haematology|November 26, 2022
Amp(1q) and tetraploidy are commonly acquired chromosomal abnormalities in relapsed multiple myelomaMaurus Locher, Emina Jukic, Verena Vogi, et al.Circulation Research|October 9, 2010
The neuropeptide catestatin acts as a novel angiogenic cytokine via a basic fibroblast growth factor-dependent mechanismMarkus Theurl, Wilfried Schgoer, Karin Albrecht, et al.Blood|July 7, 2011
Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in ratsIgor Theurl, Andrea Schroll, Thomas Sonnweber, et al.Bone Marrow Transplantation|March 6, 2019
The role of checkpoint blockade after allogeneic stem cell transplantation in diseases other than Hodgkin's LymphomaTobias A W Holderried, Alessia Fraccaroli, Martin Schumacher, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2016
Leukemic Stem Cell Quantification in Newly Diagnosed Patients With Chronic Myeloid Leukemia Predicts Response to Nilotinib TherapyNoortje Thielen, Johan Richter, Matthias Baldauf, et al.European Journal of Haematology|May 24, 2018
Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosisSharifah Shahnaz Syed Abd Kadir, Maximilian Christopeit, Gerald Wulf, et al.Gut|September 20, 2015
Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosisSabine Klein, Johanna Rick, Jennifer Lehmann, et al.Pageof 34